Irinotecan Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 31 USDMF, 12 CEP/COS, 10 JDMF, 7 EU WC, 12 KDMF, 12 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

INTERMEDIATES

19 Intermediates Suppliers

19 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

217 FDF Dossiers, 65 FDA Orange Book, 93 Europe, 7 Canada, 14 Australia, 16 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 300MG/15ML (20MG/ML), INJECTABLE;INJECTION - 40MG/2ML (20MG/ML), INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Actylis, 1 BioSpectra, 4 Nippon Fine Chemical, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Film Formers & Plasticizers, 7 Parenteral, 4 Fillers, Diluents & Binders, 4 Taste Masking, 4 Coating Systems & Additives, 3 Surfactant & Foaming Agents, 2 Co-Processed Excipients, 2 Chewable & Orodispersible Aids, 2 Emulsifying Agents, 2 Topical, 1 Soft Gelatin, 1 Direct Compression, 1 Thickeners and Stabilizers, 1 Solubilizers, 1 Dry Powder Inhalation